Australia’s Fastest Growing Medical Cannabis Company

About CannaPacific

About Us

CannaPacific is an Australian biotech company focused on the cannabinoid pharmaceutical sector.

Our medical team is headed by Dr Mike Fay, a leading Oncologist and Dr Erica Cameron-Taylor, a Palliative Care Specialist. Our agricultural R&D is headed by Plant Scientist Professor Chris Grof and Tim Bowser, a former executive from the Australian opiate industry. Both are highly experienced in genomic-based molecular breeding of medicinal plants for the production of pharmaceutical actives.

Our equity partner, Aleafia Health Inc, is Canada’s largest medical cannabis clinical network with a 10 million point medical cannabis dataset. Aleafia Health Inc educational network includes 900+ Canadian MDs and Nurse Practitioners and over 70,000 Patients. Aleafia Health manufactures medicinal cannabis products for CannaPacific for supply to the Australian market as unregistered medicines under a Special Access Scheme.

CannaPacific has engaged internationally recognised service and technology providers for the development of registered cannabinoid-based medicines.

CannaPacific is licenced by the Australian Government to cultivate and research medicinal cannabis. CannaPacific owns a 10,000 sqm Dutch glasshouse near Byron Bay, NSW with a retrofit program underway to optimise operations for the cultivation of medical cannabis to GACP & GMP Standards.

get More information

About CannaPacific

Our Team

Meet the team bringing Medical grade cannabis to you.

Our Facilities

Learn about our growing facilities and processes.

Our Values

We’re Australia’s fastest-growing medical cannabis company, this is why.